- Home
- FLNC vs ZLAB Comparison
FLNC vs ZLAB Comparison
Compare FLNC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNC
- ZLAB
- Stock Information
- Founded
- FLNC 2018
- ZLAB 2013
- Country
- FLNC United States
- ZLAB China
- Employees
- FLNC 1595
- ZLAB N/A
- Industry
- FLNC Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- FLNC Miscellaneous
- ZLAB Health Care
- Exchange
- FLNC Nasdaq
- ZLAB Nasdaq
- Market Cap
- FLNC 802.6M
- ZLAB 3.6B
- IPO Year
- FLNC 2021
- ZLAB 2017
- Fundamental
- Price
- FLNC $8.32
- ZLAB $36.40
- Analyst Decision
- FLNC Buy
- ZLAB Buy
- Analyst Count
- FLNC 18
- ZLAB 5
- Target Price
- FLNC $8.58
- ZLAB $54.28
- AVG Volume (30 Days)
- FLNC 5.5M
- ZLAB 886.5K
- Earning Date
- FLNC 08-06-2025
- ZLAB 08-05-2025
- Dividend Yield
- FLNC N/A
- ZLAB N/A
- EPS Growth
- FLNC N/A
- ZLAB N/A
- EPS
- FLNC N/A
- ZLAB N/A
- Revenue
- FLNC $2,329,871,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- FLNC $3.61
- ZLAB $44.07
- Revenue Next Year
- FLNC $25.79
- ZLAB $49.13
- P/E Ratio
- FLNC N/A
- ZLAB N/A
- Revenue Growth
- FLNC 6.08
- ZLAB 43.72
- 52 Week Low
- FLNC $3.46
- ZLAB $16.01
- 52 Week High
- FLNC $24.00
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- FLNC 83.84
- ZLAB 52.67
- Support Level
- FLNC $6.06
- ZLAB $34.79
- Resistance Level
- FLNC $6.65
- ZLAB $36.73
- Average True Range (ATR)
- FLNC 0.57
- ZLAB 1.23
- MACD
- FLNC 0.27
- ZLAB -0.46
- Stochastic Oscillator
- FLNC 99.55
- ZLAB 25.91
About FLNC Fluence Energy Inc.
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.